Clinical studies with curcumin

Advances in Experimental Medicine and Biology

Volumn 595, Issue , 2007, Pages 471-480

  Hsu, Chih Hung ^a   Cheng, Ann Lii ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; GEMCITABINE; GINKGO BILOBA EXTRACT; PHENYLBUTAZONE; PIPERINE; PLACEBO; SULINDAC; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CHRONIC PANCREATITIS; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; ENTERITIS; FECES COLOR; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; HYPERLIPIDEMIA; IRIDOCYCLITIS; LACTATE DEHYDROGENASE BLOOD LEVEL; NAUSEA; PRECANCER; PRIORITY JOURNAL; PSORIASIS; RASH; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

EID: 84934444244     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-46401-5_21     Document Type: Review

References (21)

1. K. L. Grant and C. D. Schneider, Tumeric. Am J Health-Syst Pharm 57, 1121-1122 (2000).
2. J. K. Lin and S. Y. Lin-Shiau, Mechanisms of cancer chemoprevention by curcumin. Proc Natl Sci Counc Repub China B. 25(2), 59-66 (2001).
3. B. B. Aggarwal, A. Kumar, and A. C. Bharti, Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 23, 363-398.
4. B. Joe, M. Vijaykumar, and B. R. Lokesh, Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci Nutr 44(2), 97-111 (2004).
5. R. A. Sharma, A. J. Gescher, and W. P. Steward, Curcumin: The story so far. Eur J Cancer 41, 1995-1968 (2004).
6. Cheng, A. L., Hsu, C. H., Lin, J. K., Hsu, M. M., Ho, Y. F., Shen, T. S., Ko, J. Y., Lin, J. T., Lin, B. R., Wu, M. S., Yu, H. S., Jee, S. H., Chen, G. S., Chen, T. M., Chen, C. A., Lai, M. K., Pu, Y. S., Pan, M. H., Wang, Y. J., Tsai, C. C., and Hsieh, C. Y., 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21(4B), 2895-2900.
7. R. A. Sharma, H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7(7), 1894-1900 (2001).
8. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher, and W. P. Steward, Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance. Clin Cancer Res 10(20), 6847-6854 (2004).
9. C. D. Lao, M. T. Ruffin 4th, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. BoggsJ. Crowell, C. L. Rock, and D. E. Brenner, Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10-13 (2006).
10. G. Garcea, D. J. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, A. J. Gescher, and D. P. Berry, Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90(5), 1011-1015 (2004).
11. G. Garcea, D. P. Berry, D. J. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, and A. J. Gescher, Consumption of the putative chemopreventive agent curcumin by cancer patients: Assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14(1), 20-125 (2005).
12. S. D. Deodhar, R. Sethi, and R. C. Srimal, Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res 71, 632-634.
13. B. Lal, A. K. Kapoor, O. P. Asthana, P. K. Agrawal, R. Prasad, P. Kumar, and R. C. Srimal, Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13(4), 318-322 (1999).
14. B. Lal, A. K. Kapoor, P. K. Agrawal, O. P. Asthana, and R. C. Srimal, Role of curcumin in idiopathic inflammatory orbital pseudotumours. Phytother Res 14(6), 443-447 (2000).
15. P. R. Holt, S. Katz, and R. Kirshoff, Curcumin therapy in inflammatory bowel disease: A pilot study. Dig Dis Sci 50(11), 2191-2193 (2005).
16. S. Durgaprasad, C. G. Pai, Vasanthkumar, J. F. Alvres, and S. Namitha, A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 122(4), 315-318 (2005).
17. M. C. Heng, M. K. Song, J. Harker, and M. K. Heng, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143(5), 937-949 (2000).
18. R. Kuttan, P. C. Sudheeran, and C. D. Josph, Turmeric and curcumin as topical agents in cancer therapy. Tumori 73(1), 29-31 (1987).
19. J. S. James, Curcumin: Clinical trial finds no antiviral effect. AIDS Treat News 242, 1-2 (1996).
20. K. B. Soni and R. Kuttan, Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 36(4), 273-275 (1992).
21. J. M. Ringman, S. A. Frautschy, G. M. Cole, D. L. Masterman, and J. L. Cummings, A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2(2), 131-136 (2005).